ArticleBiomedicines2025

Mandatory Biological/Targeted Synthetic Disease-Modifying Antirheumatic Drugs Dose Reduction on Risk of Serious Infections in Patients with Rheumatoid Arthritis: A Nationwide Nested Case-Control Study.

Der-Yuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.